Regulation of human immunodeficiency virus type 1 (HIV-1) replication by viral and cellular proteins. Using a mouse model, human cells will be treated with a very powerful antiviral protein using a gene therapy approach so as to block the human immunodeficiency virus (HIV) from growing. By learning how this antiviral protein works, this project will assist in the development of new strategies to treat HIV infection.